A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group

Journal:

The Lancet Oncology

Published:

2025-11-26

DOI:

10.1016/s1470-2045(25)00534-0

Affiliations:

33

Authors:

49

Go to article

Institutions	Authors	Share
University of San Francisco (USF), United States of America (USA)	5.000000	0.10
Erasmus University Medical Center (Erasmus MC), Netherlands	3.500000	0.07
Yonsei University, South Korea	3.000000	0.06
The University of Texas Health Science Center at Houston (UTHealth), United States of America (USA)	3.000000	0.06
University Hospital of Erlangen, FAU, Germany	3.000000	0.06
Massachusetts General Hospital (MGH), United States of America (USA)	2.500000	0.05
University of Cologne (UoC), Germany	2.500000	0.05
IRCCS Ospedale Galeazzi - Sant'Ambrogio, Italy	2.500000	0.05
University of Milan (UNIMI), Italy	2.500000	0.05
Bern University Hospital, Switzerland	2.000000	0.04
Ludwig Maximilians University of Munich (LMU), Germany	2.000000	0.04
University of Freiburg (Uni Freiburg), Germany	2.000000	0.04
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	2.000000	0.04
Sahlgrenska University Hospital (SU), GU, Sweden	2.000000	0.04
Oslo University Hospital (OUS), Norway	2.000000	0.04
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)	2.000000	0.04
University of Turin (UNITO), Italy	2.000000	0.04
Technical University of Munich (TUM), Germany	2.000000	0.04
University Hospital Zurich (UHZ), Switzerland	1.000000	0.02
Brigham and Women's Hospital (BWH), United States of America (USA)	1.000000	0.02
Medical Center Haaglanden (MCH), Netherlands	0.500000	0.01
DKTK Partner Site Berlin, Germany	0.500000	0.01
Hospital Fulda, Germany	0.500000	0.01

Interested in Oncology and Carcinogenesis?